Combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression (original) (raw)

• Dias N, Stein CA . Antisense oligonucleotides: basic concepts and mechanisms. Mol Cancer Ther 2002; 1: 347–355.
  Article CAS Google Scholar
• Dove A . Antisense and sensibility. Nat Biotechnol 2002; 20: 121–124.
  Article CAS Google Scholar
• Opalinska JB, Gewirtz AM . Nucleic-acid therapeutics: basis principles and recent application. Nat Rev Drug Discovery 2002; 1: 503–514.
  Article CAS Google Scholar
• Sazani P, Vacek MM, Kole R . Short-term and long-term modulation of gene expression by antisense therapeutics. Curr Opin Biotechnol 2002; 13: 468–472.
  Article CAS Google Scholar
• Kurrech J . Antisense technologies: improvement through novel chemical modifications. Eur J Biochem 2003; 270: 1628–1644.
  Article Google Scholar
• Nielsen PE . Peptide nucleic acids as therapeutic agents. Curr Opin Struct Biol 1999; 9: 353–357.
  Article CAS Google Scholar
• Good L et al. Bactericidal antisense effects of peptide-PNA conjugates. Nat Biotechnol 2001; 19: 360–364.
  Article CAS Google Scholar
• Egholm M et al. PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules. Nature 1993; 365: 566–568.
  Article CAS Google Scholar
• Nielsen PE, Egholm M, Berg RH, Buchardt O . Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 1991; 254: 1497–1500.
  Article CAS Google Scholar
• Koppelhus U, Nielsen PE . Cellular delivery of peptide nucleic acid. Adv Drug Delivery Rev 2003; 55: 267–280.
  Article CAS Google Scholar
• Tyler BM et al. Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood–brain barrier and specifically reduce gene expression. Proc Natl Acad Sci USA 1999; 96: 7053–7058.
  Article CAS Google Scholar
• Aldrian-Herrada G et al. A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucleic Acids Res 1998; 26: 4910–4916.
  Article CAS Google Scholar
• Rapozzi V et al. Antiproliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids. Nucleic Acids Res 2002; 30: 3712–3721.
  Article CAS Google Scholar
• Cutrona G et al. Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat Biotechnol 2000; 18: 300–302.
  Article CAS Google Scholar
• Stock RP et al. Inhibition of gene expression in Entamoeba histolytica with antisense peptide nucleic acid oligomers. Nat Biotechnol 2001; 19: 231–234.
  Article CAS Google Scholar
• Braun K et al. A biological transporter for the delivery of peptide nucleic acids (PNAs) to the nuclear compartment of living cells. J Mol Biol 2002; 318: 237–243.
  Article CAS Google Scholar
• Pooga M et al. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol 1998; 16: 857–861.
  Article CAS Google Scholar
• Koppelhus U et al. Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acids Drug Dev 2002; 2: 51–63.
  Article Google Scholar
• Branden LJ, Christensson B, Smith CI . In vivo nuclear delivery of oligonucleotides via hybridizing bifunctional peptides. Gene Therapy 2001; 8: 84–87.
  Article CAS Google Scholar
• Sazani P et al. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat Biotechnol 2002; 12: 1228–1233.
  Article Google Scholar
• Tackett A, Corey D, Raney K . Non-Watson–Crick interactions between PNA and DNA inhibit the ATPase activity of bacteriophage T4 Dda helicase. Nucleic Acids Res 2002; 30: 950–957.
  Article CAS Google Scholar
• Braasch D, Corey D . Synthesis, analysis, purification, and intracellular delivery of peptide nucleic acids. Methods 2001; 23: 97–107.
  Article CAS Google Scholar
• Weiler J et al. Hybridisation based DNA screening on peptide nucleic acid (PNA) oligomer arrays solid phase pythesis of directly linked PNA-RNA-hybrids. Nucleic Acids Res 1997; 25: 2792–2799.
  Article CAS Google Scholar
• Bergman F, Bannwarth W, Tam S . Solid phase synthesis of directly linked PNA-DNA hybrids. Tetrahedron Lett 1995; 36: 6823–6826.
  Article Google Scholar
• Efimov VA et al. Detection of the 5′-cap structure of messenger RNAs with the use of the cap-jumping approach. Nucleic Acids Res 2001; 29: 4751–4759.
  Article CAS Google Scholar
• Efimov V et al. PNA-related oligonucleotide mimics and their evaluation for nucleic acid hybridization studies and analysis. Nucleosides Nucleotides Nucleic Acids 2001; 20: 419–428.
  Article CAS Google Scholar
• Efimov VA, Chakhmakhcheva OG . Conjugates of polyacrylamide with oligonucleotides and their mimetics for diagnostic purposes. Bioorg Khim 1999; 25: 848–854.
  CAS PubMed Google Scholar
• Morris MC et al. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 2001; 19: 1173–1176.
  Article CAS Google Scholar
• Morgan DO . Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997; 13: 261–291.
  Article CAS Google Scholar
• Sausville EA . Complexities in the development of cyclin-dependent kinase inhibitor drugs. Trends Mol Med 2002; 8: 32–37.
  Article Google Scholar
• Morris MC, Gondeau C, Tainer JA, Divita G . Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk.. J Biol Chem. 2002; 277: 23847–23853.
  Article CAS Google Scholar
• Labbé JC et al. Purification of MPF from starfish: identification as the H1 histone kinase p34cdc2 and a possible mechanism for its periodic activation. Cell 1989; 57: 253–263.
  Article Google Scholar
• Peter M et al. Initial activation of cyclin B1-cdc2 kinase requires phosphorylation of cyclin B1. EMBO Rep 2002; 3: 551–556.
  Article CAS Google Scholar
• Pichon C, Monsigny M, Roche AC . Intracellular localization of oligonucleotides: influence of fixative protocols. Antisense Nucleic Acids Drug Dev 1999; 9: 89–93.
  Article CAS Google Scholar
• Richard JP et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003; 278: 585–590.
  Article CAS Google Scholar
• Mologni L, Marchesi E, Neilsen P, Gambacorti-Passerini C . Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-a and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid. Cancer Res 2001; 61: 5468–5473.
  CAS PubMed Google Scholar
• Zhang X, Ishihara T, Corey DR . Strand invasion by mixed base PNAs and a PNA-peptide chimera. Nucleic Acids Res 2000; 28: 3332–3338.
  Article CAS Google Scholar
• Nielsen PE, Egholm M, Buchardt O . Sequence-specific transcription arrest by peptide nucleic acid bound to the DNA template strand. Gene 1994; 149: 139–145.
  Article CAS Google Scholar
• Hanvey JC et al. Antisense and antigene properties of peptide nucleic acids. Science 1992; 258: 1481–1485.
  Article CAS Google Scholar
• Lohse J, Dahl O, Nielsen PE . Double duplex invasion by peptide nucleic acid: a general principle for sequence-specific targeting of double-stranded DNA. Proc Natl Acad Sci USA 1999; 96: 11804–11808.
  Article CAS Google Scholar
• Langel U (ed). Cell Penetrating Peptides: Processes and Application. Pharmacology & Toxicology Series. CRC Press: Boca Raton, FL, 2002.
  Google Scholar
• Morris MC et al. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res 1997; 25: 2730–2736.
  Article CAS Google Scholar
• Kurreck J, Bieber B, Jahnel R, Erdmann VA . Comparative study of DNA enzymes and ribozymes against the same full-length messenger RNA of the Vanilloid Receptor subtype I. J Biol Chem 2002; 277: 7099–7107.
  Article CAS Google Scholar